Drug-labels.com

Bicalutamide Tablets: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
50 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Bicalutamide Tablets

ABOUT THIS MEDICATION

What the medication is used for:

Bicalutamide Tablets are used in the treatment of advanced prostate cancer in combination with other drugs (LHRH analogues) which reduce the levels of androgens in the body or surgery.

What it does:

Androgens are male sex hormones within the body which can cause tumor growth within the prostate. Bicalutamide Tablets belong to a group of medicines called non-steroidal anti-androgens. This means that Bicalutamide Tablets interfere with some of the actions of androgens to prevent the tumor from growing.

What are the Stages of Prostate Cancer:

  • Localized disease - the early stages of disease

    when prostate cancer is confined to the prostate gland.

  • Locally advanced disease - the disease

    progresses and the cancer spreads to other tissues within the pelvis.

  • Advanced or metastatic disease - the disease

    progresses to other parts of the body.

The PSA (Prostate Specific Antigen) test is a simple blood test for a protein produced by the prostate (PSA). This test has helped in the detection of prostate cancer resulting in an increase in the number of men whose prostate cancer is detected at an early stage.

What are the Treatment Options for Localized Prostate Cancer:

The optimal treatment for a given individual will depend on the specific circumstances of his case. For localized disease, patients are usually offered one of the following:

  • Surgery to remove the prostate
  • Targeted radiotherapy to kill the cancer cells in the prostate
  • No treatment initially (watchful waiting)

    whereby the patient is monitored until there are signs of progression before treatment is started.

When it should not be used:

  • Do not take Bicalutamide Tablets if you have early phase (localized) prostate cancer requiring watchful waiting.
  • Do not take Bicalutamide Tablets if you are allergic to bicalutamide or any of the non-medicinal ingredients in Bicalutamide Tablets
  • Bicalutamide Tablets must not be taken by women, including pregnant women or mothers who are breast-feeding their babies.

  • Bicalutamide Tablets must not be given to children.

What the medicinal ingredient is:

The active ingredient in Bicalutamide Tablets is bicalutamide.

What the non-medicinal ingredients are:

Each tablet contains the following inactive ingredients: colloidal silicon dioxide, hypromellose, lactose monohydrate, magnesium stearate, polyethylene glycol, povidone, sodium starch glycolate, titanium dioxide

What dosage forms it comes in:

Bicalutamide Tablets come in tablets containing 50 milligrams (mg) of bicalutamide as the active ingredient.

Bicalutamide Tablets come in blister strips of 10 tablets, 30 tablets per package.

WARNINGS AND PRECAUTIONS

BEFORE you use Bicalutamide Tablets talk to your doctor or pharmacist if:

  • You have liver disease.
  • You have lung disease.
  • You have low bone mineral density (BMD).
  • You have low red blood cell count (anemia).
  • You are taking blood thinners or medicines to

    prevent blood clots.

  • You have heart or blood vessel conditions,

    including heart disease, a heart condition called “long QT syndrome” or family history of this heart condition, heart rhythm problems (arrhythmia), or are being treated with medicines for these conditions. The risk of heart rhythm problems may be increased in such patients when using Bicalutamide Tablets.

If you go into hospital let the medical staff know you are taking Bicalutamide Tablets.

If you are taking Bicalutamide Tablets, you and/or your partner should use birth control while you are taking Bicalutamide Tablets and for at least 130 days after stopping Bicalutamide Tablets. Talk to your doctor if you have any questions about birth control.

Bicalutamide Tablets may have an effect on male fertility which could be reversible.

Avoid direct exposure to excessive sunlight or UV-light while you are taking Bicalutamide Tablets.

Bicalutamide Tablets may make you feel sleepy. Do not drive or use machines until you know how the drug affects you.

INTERACTIONS WITH THIS MEDICATION

Please inform your doctor if you are taking or have recently taken any other medicines, even those not prescribed.

  • In particular please inform your doctor if you are taking blood thinners like warfarin or medicines to prevent blood clots.If you are taking any medicines that may increase the risk of having an abnormal heart rhythm.
  • If you are taking medicines used to treat heart rhythm problems.

PROPER USE OF THIS MEDICATION

Follow your doctor's instructions about when and how to take your tablets. Ask your doctor or pharmacist if you are not sure.

  • The usual adult dose is 50 mg daily.
  • Swallow the tablet(s) whole with a drink of water.
  • Try to take your dose at the same time each day.

During the first few months of use, you may be monitored by your physician for signs of changes in your liver function. In approximately 2.0% of patients, such changes may lead to withdrawal of therapy.

If you experience a rise in PSA while taking Bicalutamide Tablets your physician may discontinue Bicalutamide Tablets for several weeks in order to monitor your condition off treatment.

Overdose:

In case of drug overdose, contact a health care
practitioner, hospital emergency department or
regional Poison Control Centre immediately, even
if there are no symptoms.

Missed Dose:

You should take Bicalutamide Tablets as prescribed. However, if you miss a dose do not take an extra dose. Just resume your usual schedule.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medicines, Bicalutamide Tablets can have side effects.

Side effects that are very common (more than 10 in every 100 patients are likely to have them):

  • dizziness
  • Bicalutamide Tablets should only be prescribed by a doctor experienced with the treatment of prostate cancer.
  • Bicalutamide Tablets 150 mg/day dose should not be used.
  • Bicalutamide Tablets may rarely be associated with liver failure; some cases have been fatal.
  • Bicalutamide Tablets may be associated with uncommon cases of interstitial lung disease; some cases have been fatal.
  • nausea
  • hot flushes
  • feeling weak
  • decreased red blood cell count (anemia)
  • puffiness/swelling
  • constipation

Side effects that are common (1 to 10 in every 100 patients are likely to have them):

  • loss of appetite
  • reduced sex drive
  • depression
  • sleepiness
  • indigestion
  • flatulence
  • loss of hair or hair re-growth
  • rash
  • itching
  • dry skin
  • impotence
  • chest pain
  • tender or enlarged breast tissue
  • weight gain
  • heart failure
  • heart attack

Occasionally Bicalutamide Tablets may be associated with changes in your blood which may require your doctor to do certain blood tests.

SERIOUS SIDE EFFECTS, HOW OFTEN
THEY HAPPEN AND WHAT TO DO
ABOUT THEM
Symptom / effect

Talk with your doctor

or

pharmacist

Stop taking drug and call your doctor or

pharma-cist

Only if

severe

In all cases
Very Common (more than 10 in every 100 patients are likely to have them)
Blood in urine✓
Abdominal pain✓
Common (1 to 10 in every 100 patients are likely to have them)
Yellow skin and eyes (jaundice). These may be symptoms of liver damage.✓
SERIOUS SIDE EFFECTS, HOW OFTEN
THEY HAPPEN AND WHAT TO DO
ABOUT THEM
Heart failure (reduced heart function)✓
Heart attack✓
Uncommon (1 to 10 in every 1 000 patients are likely to have them)
Serious breathlessness, or sudden worsening of breathlessness, possibly with a cough or fever. Some patients taking Bicalutamide Tablets get an inflammation of the lungs called interstitial lung disease.✓
Severe itching of the skin (with raised lumps) or swelling of the face, lips, tongue and/or throat, which may cause difficulty in swallowing✓
Rare (1 to 10 in every 10 000 patients are likely to have them)
Increased skin sensitivity to sunlight√

Tell your doctor or pharmacist if you think you have any of these or any other problems with your tablets.

This is not a complete list of side effects. For any unexpected effects while taking Bicalutamide Tablets, contact your doctor or pharmacist.

HOW TO STORE IT

  • Keep your tablets in the container they came in.
  • Do not take your tablets after the expiry date on the container. Dispose of them in an appropriate way.
  • Keep your tablets in a safe place where children cannot see or reach them. Your tablets could harm them.
  • Keep your tablets at room temperature (15 °C –

    30 °C).

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction

    Reporting ( https://www.canada.ca/en/health-canada/services/drugs-health-

    products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or

  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be obtained by contacting the sponsor, Fresenius Kabi Canada Ltd., at 1-877-821-7724.

Fresenius Kabi Canada Ltd.

165 Galaxy Blvd, Suite 100

Toronto, ON, M9W 0C8

Last revised: October 17, 2017

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02360098

Revision date stated in the text: October 17, 2017

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Bicalutamide Tablets

Rx or OTC
Prescription (Rx)?
DIN 02360098
Schedule(s) PRESCRIPTION
Active ingredient(s) Bicalutamide 50 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L02 Endocrine therapy antineoplastic and immunomodulating agents
      1. L02B Hormone antagonists and related agents
        1. L02BB Anti-androgen hormone antagonists and related agents
          1. L02BB03 Bicalutamide
Company FRESENIUS KABI CANADA LTD
Current status Cancelled Pre Market
Current status date March 10, 2023

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.